stoxline Quote Chart Rank Option Currency Glossary
Walgreens Boots Alliance, Inc. (WBA)
15.39  0.5 (3.36%)    05-30 16:00
Open: 14.92
High: 15.56
Volume: 12,114,158
Pre. Close: 14.89
Low: 14.875
Market Cap: 13,277(M)
Technical analysis
2024-05-30 4:45:20 PM
Short term     
Mid term     
Targets 6-month :  20.11 1-year :  21.99
Resists First :  17.22 Second :  18.82
Pivot price 16.92
Supports First :  14.61 Second :  12.16
MAs MA(5) :  15.52 MA(20) :  17.05
MA(100) :  20.13 MA(250) :  23.28
MACD MACD :  -0.8 Signal :  -0.6
%K %D K(14,3) :  8.6 D(3) :  5.1
RSI RSI(14): 32.4
52-week High :  32.88 Low :  14.61
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ WBA ] has closed above bottom band by 16.6%. Bollinger Bands are 82.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 15.58 - 15.67 15.67 - 15.75
Low: 14.65 - 14.76 14.76 - 14.86
Close: 15.22 - 15.39 15.39 - 15.54
Company Description

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Headline News

Thu, 30 May 2024
Walgreens: Another Dividend Cut Could Be Coming Soon (NASDAQ:WBA) - Seeking Alpha

Thu, 30 May 2024
Walgreens: Another Dividend Cut Could Be Coming Soon (NASDAQ:WBA) - Seeking Alpha

Thu, 30 May 2024
Investors Buy High Volume of Put Options on Walgreens Boots Alliance (NASDAQ:WBA) - Defense World

Wed, 29 May 2024
Walgreens Down Over 3% - What's Going On? - Walgreens Boots Alliance (NASDAQ:WBA) - Benzinga

Wed, 29 May 2024
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by Assetmark Inc. - Defense World

Tue, 28 May 2024
Is Walgreens Boots Alliance (WBA) a Smart Investment or a Value Trap? An In-Depth Exploration -

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Pharmaceuticals
Shares Out 863 (M)
Shares Float 713 (M)
Held by Insiders 17.3 (%)
Held by Institutions 61.7 (%)
Shares Short 40,160 (K)
Shares Short P.Month 35,220 (K)
Stock Financials
EPS -7
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 15.63
Profit Margin -4.2 %
Operating Margin 1.7 %
Return on Assets (ttm) 1.1 %
Return on Equity (ttm) -57.2 %
Qtrly Rev. Growth 6.3 %
Gross Profit (p.s.) 0
Sales Per Share 167.61
EBITDA (p.s.) 4.3
Qtrly Earnings Growth 0 %
Operating Cash Flow 101 (M)
Levered Free Cash Flow 335 (M)
Stock Valuations
PE Ratio -2.2
PEG Ratio -0.7
Price to Book value 0.98
Price to Sales 0.09
Price to Cash Flow 131.45
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android